title: Active oxygen in neuromuscular disorders.
abstract: Although muscle and nerve are reasonably well protected against active oxygen and related free radicals, environmental or inherited malfunctions can overpower their defences. Active oxygen is involved in many neuropathies and myopathies. In every case the damage is caused by agents which exert effects disproportionately greater than the quantities encountered, through a variety of amplification mechanisms. We can categorize these amplification mechanisms as follows: (a) non-replacement of targets (e.g. loss of genetic information, ataxia telangectasia being an hereditary ataxia in which an oxygen mediated chromosomal instability is apparent), (b) non-removal of unwanted materials (e.g. lipofuscin accumulation in brain and heart), (c) redox cycling, usually involving catalysis by trace-metal ions (e.g. some forms of Parkinsonism), (d) non-redox catalysis (e.g. toxicity in cardiac muscle or brain due to vanadium or aluminium respectively), (e) modification of ion transport (e.g. calcium ionophore or acrylamide induce histopathological changes in muscle, similar in some respects to those seen in Duchenne muscular dystrophy), (f) compromised defences (e.g. muscle and nerve become particularly susceptible to free radical damage after loss of the protective actions of vitamin E), and (g) amplification by inflammatory and immune responses (e.g. multiple sclerosis, reperfusion injury to brain and heart, and traumatic injury to nervous tissue). Unfortunately, a variety of therapeutic agents which might be expected to protect against almost every conceivable form of oxygen mediated damage have proved clinically ineffective in most of these disorders. The reasons for this will be explored with an emphasis on common features, differences, mechanisms, and potential therapeutic approaches.
authors.affiliation: Faculty of Applied Sciences, School of Kinesiology, Simon Fraser University, Burnaby, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Davison
authors.forename: G
authors.initials: G
authors.lastname: Tibbits
authors.forename: Z G
authors.initials: ZG
authors.lastname: Shi
authors.forename: J
authors.initials: J
authors.lastname: Moon
mesh_terms: D006801:Humans; D009468:Neuromuscular Diseases / Q000503:physiopathology*; D010100:Oxygen / Q000502:physiology*
chemical_list: D010100:Oxygen